Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,240.00
Bid: 1,240.00
Ask: 1,245.00
Change: -37.00 (-2.90%)
Spread: 5.00 (0.403%)
Open: 1,277.00
High: 1,284.00
Low: 1,240.00
Prev. Close: 1,277.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Mar 2024 14:30

RNS Number : 8693F
Indivior PLC
06 March 2024
 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that on March 5, 2024, Mark Crossley, Chief Executive Officer and a PDMR, received 91,204 ordinary shares in the Company of $0.50 each ('Shares').

This arose as a result of the release of awards granted on March 5, 2019 and August 8, 2019 under the Indivior Long-Term Incentive Plan, which vested in respect of a total of 159,311 Shares on March 5, 2021 and which were then subject to a two-year post-vesting holding period. Following the end of the holding period, the Shares were released on March 5, 2024 on a net settled basis, resulting in the delivery of 91,204 Shares.

Following this transaction, Mark Crossley has a beneficial interest in 181,236 Shares in the Company.

This notification is made in accordance with the requirements of the UK Market Abuse Regulation.

Kathryn Hudson

Company Secretary

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Mark Crossley

2

 

Reason for the notification

 

a)

 

Position/status

  

Director / PDMR - Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Indivior PLC

b)

 

LEI

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Release of Shares following the end of the two-year holding period after vesting of an award granted under the Indivior Long-Term Incentive Plan.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

N/A

91,204

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 5, 2024

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUPGWUPCGCQ
Date   Source Headline
31st Jul 20187:00 amRNSIndivior Preliminary Injunction Upheld
30th Jul 20187:01 amRNSDRL's Appeal of Indivior's PI Granted-in-Part
30th Jul 20187:00 amRNSUS FDA Approves Indivor's PERSERIS(TM)
27th Jul 20188:40 amRNSHolding(s) in Company
26th Jul 20189:01 amRNSHolding(s) in Company
25th Jul 20187:00 amRNSHalf-year Report
24th Jul 20187:00 amRNSHolding(s) in Company
16th Jul 20187:00 amRNSUS Court Grants Indivior Preliminary Injunction
13th Jul 20184:39 pmRNSHolding(s) in Company
12th Jul 20185:16 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSIndivior Sees FY18 Guidance Below Expectations
10th Jul 20187:00 amRNSNotice of Results
3rd Jul 20187:01 amRNSHolding(s) in Company
3rd Jul 20187:00 amRNSHolding(s) in Company
29th Jun 20187:00 amRNSIndivior's Temporary Restraining Order is Extended
21st Jun 20182:56 pmRNSHolding(s) in Company
20th Jun 20187:00 amRNSHolding(s) in Company
18th Jun 20187:00 amRNSIndivior Is Granted Temporary Restraining Order
15th Jun 20183:56 pmRNSHolding(s) in Company
15th Jun 20181:59 pmRNSIndivior Responds to Generic SUBOXONE ® Approvals
7th Jun 20189:30 amRNSHolding(s) in Company
1st Jun 20187:00 amRNSTotal Voting Rights
31st May 20187:00 amRNSCalifornia Department of Insurance subpoena
25th May 20182:25 pmRNSSUBLOCADE(TM) Submitted in Australia for Approval
24th May 20187:00 amRNSIndivior Participating in Jefferies NYC Conference
16th May 20185:50 pmRNSResult of AGM
14th May 20187:00 amRNSIndivior settlement with Par Pharmaceutical
10th May 201811:40 amRNSBlock listing Interim Review
4th May 20182:13 pmRNSDirector/PDMR Shareholding
2nd May 20187:00 amRNS1st Quarter Results
20th Apr 20187:00 amRNSIndivior's SUBLOCADE NDS Accepted by Health Canada
12th Apr 20183:56 pmRNSHolding(s) in Company
11th Apr 20184:02 pmRNSDirector Declaration
11th Apr 20187:00 amRNSNotice of Results
6th Apr 20189:31 amRNSHolding(s) in Company
5th Apr 20187:00 amRNSIndivior Asserts New SUBOXONE(R) Film Patent
4th Apr 20189:28 amRNSDirector/PDMR Shareholding
3rd Apr 20189:33 amRNSHolding(s) in Company
3rd Apr 20187:00 amRNSTotal Voting Rights
29th Mar 20187:00 amRNSIndivior and C4X Enter Licensing Agreement
27th Mar 20184:13 pmRNSHolding(s) in Company
23rd Mar 20187:00 amRNSIndivior Responds to Court Ruling ANDA litigation
22nd Mar 20181:39 pmRNSAnnual Financial Report
13th Mar 20183:14 pmRNSDirector/PDMR Shareholding
12th Mar 20184:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20182:51 pmRNSHolding(s) in Company
2nd Mar 201810:24 amRNSHolding(s) in Company
1st Mar 20181:00 pmRNSIndivior Announces SUBLOCADET Available in US
1st Mar 20187:00 amRNSTotal Voting Rights
28th Feb 20185:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.